St. Petersburg authorities have signed with one international and three domestic pharmaceutical company memoranda of intent to establish production facilities in the Novo-Orlovsky site of a special economic zone, said on Friday, the press service of the government of the city.
International corporation Novartis, one of Europe's largest manufacturers of pharmaceutical products, will create a full cycle in 10 acres for $ 500 million. The initial production volume will reach 1.5 billion units of the drug, and by 2014 it is projected to reach 2 billion units.
Petersburg manufacturer of pharmaceutical and cosmetic products JSC "Vertex" plans within 5.0 acres to create the production of drugs worth 35 million euros. Capacity of the plant, which is scheduled to enter in 2014, will reach 100 million units per year.
Irkutsk pharmaceutical plant for the production of final dosage forms of "Pharmasyntez" will build on 4.5 acres for the production of 1.7 billion rubles, with an estimated turnover of 150 million dollars.
As deputy chairman of the Committee for Economic Development, Industrial Policy and Trade of St. Petersburg Zakhar Golant, now city officials are negotiating with companies that want to locate their production in the city or move it part of their research activities.
Overall, in 2010 in St. Petersburg was initiated by nine investment projects in the pharmaceutical industry. It is about building a full cycle of pharmaceutical companies in St. Petersburg. Businesses will be based in the offices of "Neudorf" and "Novo-Orlovsky" exclusive economic zone, as well as on the court, "Pushkin".